Accelerator Company MyRenalCare Shortlisted for the NHS Parliamentary Future NHS Award

Current DigitalHealth.London Accelerator company MyRenalCare has been shortlisted for the NHS Parliamentary Future NHS Award for their transformative work in chronic kidney disease management with the Wessex Kidney Centre, based at Portsmouth Hospital University NHS Trust.

Developed in collaboration with Portsmouth Hospital University NHS Trust, Portsmouth Hospitals Charity, the University of Portsmouth and Kidney Care UK, MyRenalCare was founded by Dr Nicholas Sangala, a Nephrology Consultant based at the Wessex Kidney Centre. Through the app, the renal team at the Wessex Kidney Centre have implemented remote monitoring and digital communication between consultants and patients.

Patients now actively manage their electronic health records, logging vital information such as blood pressure, weight, and symptoms, while blood test results are automatically uploaded. Clinicians can then review this data, make clinical decisions, and provide feedback remotely via MyRenalCare — eliminating the need for in-person, video, or telephone consultations. This enables fully virtual appointments, benefitting both patients and clinicians.

The NHS Parliamentary Future NHS Award recognises individuals or teams who have successfully implemented innovative changes to harness data and digital technology, improving patient access to services and information while enhancing staff support. The award celebrates those embracing advancements in medical technology, data, and connectivity to drive positive change within the NHS.

Patient Impact

To date, over 1,800 patients are using MyRenalCare:

• 94% of patients report feeling well looked after
• 89% of patients prefer virtual appointments to routine face-to-face appointments
• 93% of patients would recommend MyRenalCare to others
• Over 66% of patients said they felt more engaged in managing their condition
• 1,553 patients at all stages of chronic kidney disease (CKD) aged 18 to 93 years are using MyRenalCare
• 1,180 virtual appointments have been delivered to 479 patients, saving 197 hours of consultant time
• 2,510 Patient Initiated Follow-Up (PIFU) requests made
• Miles travelled by patients to receive care have been reduced by more than 50%, subsequently reducing CO2 emissions
• Outpatient capacity has increased by up to 33%, reducing the waiting time for new patient appointments from three months to two weeks
• Cost of delivering care reduced by 25% (£300 per patient per year)

MyRenalCare also allows patients to contact their clinical team through patient-initiated follow-up (PIFU), enabling them to seek help when needed and reducing reliance on primary and emergency care services. They can access educational content and videos on the platform, designed to empower them to take control of their health and manage their condition more effectively.

“MyRenalCare has really given me control over how I feel. I can report my symptoms if I am not feeling great or ask questions about my medication. It takes out that necessity of coming to the hospital, which saves time and money, and it helps you to control your disease.

Phil West
MyRenalCare User

Impact in Portsmouth Hospital University NHS Trust

• 33% increase in outpatient clinic capacity – virtual consultations using MyRenalCare take less than five minutes (compared to standard 15-minute appointments)
• 25% reduction in cost – MyRenalCare would save nearly £1.5 million per year if utilised by all renal consultants at the Trust with an additional £370,917 of societal savings (including time off work and parking fees)
• Helps to deliver towards the Trust Green Plan, due to a reduction in carbon emissions (travel miles per patient have been reduced by more than 50%)
• Supports infection prevention control measures by reducing hospital contact

It is great the app [MyRenalCare] has been shortlisted for such a prestigious award. The app is having a real impact, patients using it report feeling more engaged in managing their condition and research has proven that patients who are more engaged with their health have better health outcomes. It is also saving money and reducing CO2, all key aims for the wider NHS.

Dr Amir Bhanji
Consultant Nephrologist and Care Group Director for Renal and Transplantation at Portsmouth Hospital University NHS Trust

A panel of national judges – made up of notable figures across the healthcare sector – will now come together to select the winners of this year’s NHS Parliamentary Awards. Winners will be announced at the awards ceremony on Monday 14 October, when healthcare leaders, finalists and MPs will come together to celebrate the immense contribution which healthcare staff make to the NHS.

The full list of nominees can be found at: https://nhsparliamentaryawards.co.uk/shortlist/

MyRenalCare is currently in Cohort 8 of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England and the Mayor of London.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.